These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 18457323)

  • 1. Histologic grade is correlated with outcome after resection of hepatic neuroendocrine neoplasms.
    Cho CS; Labow DM; Tang L; Klimstra DS; Loeffler AG; Leverson GE; Fong Y; Jarnagin WR; D'Angelica MI; Weber SM; Blumgart LH; Dematteo RP
    Cancer; 2008 Jul; 113(1):126-34. PubMed ID: 18457323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progression and survival results after radical hepatic metastasectomy of indolent advanced neuroendocrine neoplasms (NENs) supports an aggressive surgical approach.
    Saxena A; Chua TC; Sarkar A; Chu F; Liauw W; Zhao J; Morris DL
    Surgery; 2011 Feb; 149(2):209-20. PubMed ID: 20674950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgical resection versus radiofrequency ablation for small hepatocellular carcinomas within the Milan criteria.
    Ueno S; Sakoda M; Kubo F; Hiwatashi K; Tateno T; Baba Y; Hasegawa S; Tsubouchi H;
    J Hepatobiliary Pancreat Surg; 2009; 16(3):359-66. PubMed ID: 19300896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resection of noncolorectal nonneuroendocrine liver metastases: a comparative analysis.
    Reddy SK; Barbas AS; Marroquin CE; Morse MA; Kuo PC; Clary BM
    J Am Coll Surg; 2007 Mar; 204(3):372-82. PubMed ID: 17324770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver-directed therapy for neuroendocrine neoplasm hepatic metastasis prolongs survival following progression after initial surgery.
    Saxena A; Chua TC; Zhao J; Morris DL
    J Surg Oncol; 2012 Mar; 105(4):342-50. PubMed ID: 22006355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimizing the surgical effort in patients with advanced neuroendocrine neoplasm hepatic metastases: a critical analysis of 40 patients treated by hepatic resection and cryoablation.
    Saxena A; Chua TC; Chu F; Al-Zahrani A; Morris DL
    Am J Clin Oncol; 2012 Oct; 35(5):439-45. PubMed ID: 21654315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgery for hepatic neuroendocrine tumors: a single institutional experience in Japan.
    Hibi T; Sano T; Sakamoto Y; Takahashi Y; Uemura N; Ojima H; Shimada K; Kosuge T
    Jpn J Clin Oncol; 2007 Feb; 37(2):102-7. PubMed ID: 17234654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Liver resection for non-colorectal, non-neuroendocrine liver metastases--is hepatic resection justified as part of the oncosurgical treatment?].
    Lehner F; Ramackers W; Bektas H; Becker T; Klempnauer J
    Zentralbl Chir; 2009 Sep; 134(5):430-6. PubMed ID: 19757343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aggressive pancreatic resection for primary pancreatic neuroendocrine tumor: is it justifiable?
    Teh SH; Deveney C; Sheppard BC
    Am J Surg; 2007 May; 193(5):610-3; discussion 613. PubMed ID: 17434366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of postoperative morbidity on long-term survival after hepatic resection for metastatic colorectal cancer.
    Ito H; Are C; Gonen M; D'Angelica M; Dematteo RP; Kemeny NE; Fong Y; Blumgart LH; Jarnagin WR
    Ann Surg; 2008 Jun; 247(6):994-1002. PubMed ID: 18520227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metastatic neuroendocrine hepatic tumors: resection improves survival.
    Musunuru S; Chen H; Rajpal S; Stephani N; McDermott JC; Holen K; Rikkers LF; Weber SM
    Arch Surg; 2006 Oct; 141(10):1000-4; discussion 1005. PubMed ID: 17043278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metastectomy for non-colorectal, non-neuroendocrine liver secondaries.
    Teo MC; Tan YM; Chung AY; Chow PK; Cheow PC; Soo KC; Hee SW; Ooi LL
    ANZ J Surg; 2006 Jul; 76(7):575-8. PubMed ID: 16813621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of survival after resection of early hepatocellular carcinoma.
    Nathan H; Schulick RD; Choti MA; Pawlik TM
    Ann Surg; 2009 May; 249(5):799-805. PubMed ID: 19387322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved outcome with cytoreduction versus embolization for symptomatic hepatic metastases of carcinoid and neuroendocrine tumors.
    Osborne DA; Zervos EE; Strosberg J; Boe BA; Malafa M; Rosemurgy AS; Yeatman TJ; Carey L; Duhaine L; Kvols LK
    Ann Surg Oncol; 2006 Apr; 13(4):572-81. PubMed ID: 16511671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The palliative benefit of aggressive surgical intervention for both hepatic and mesenteric metastases from neuroendocrine tumors.
    Chambers AJ; Pasieka JL; Dixon E; Rorstad O
    Surgery; 2008 Oct; 144(4):645-51; discussion 651-3. PubMed ID: 18847650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indications and results of liver resection and hepatic chemoembolization for metastatic gastrointestinal neuroendocrine tumors.
    Yao KA; Talamonti MS; Nemcek A; Angelos P; Chrisman H; Skarda J; Benson AB; Rao S; Joehl RJ
    Surgery; 2001 Oct; 130(4):677-82; discussion 682-5. PubMed ID: 11602899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic score predicting survival after resection of pancreatic neuroendocrine tumors: analysis of 3851 patients.
    Bilimoria KY; Talamonti MS; Tomlinson JS; Stewart AK; Winchester DP; Ko CY; Bentrem DJ
    Ann Surg; 2008 Mar; 247(3):490-500. PubMed ID: 18376195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical treatment of neuroendocrine metastases to the liver: a plea for resection to increase survival.
    Sarmiento JM; Heywood G; Rubin J; Ilstrup DM; Nagorney DM; Que FG
    J Am Coll Surg; 2003 Jul; 197(1):29-37. PubMed ID: 12831921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and imaging follow-up after exhaustive liver resection of endocrine metastases: a 15-year monocentric experience.
    Scigliano S; Lebtahi R; Maire F; Stievenart JL; Kianmanesh R; Sauvanet A; Vullierme MP; Couvelard A; Belghiti J; Ruszniewski P; Le Guludec D
    Endocr Relat Cancer; 2009 Sep; 16(3):977-90. PubMed ID: 19470616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resection of hilar cholangiocarcinoma: concomitant liver resection decreases hepatic recurrence.
    Ito F; Agni R; Rettammel RJ; Been MJ; Cho CS; Mahvi DM; Rikkers LF; Weber SM
    Ann Surg; 2008 Aug; 248(2):273-9. PubMed ID: 18650638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.